FLAP inhibitors (Merck)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameFLAP inhibitors (Merck)
Drug Alias Name5-lipooxygenase-activating protein inhibitor (Merck)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene B4 receptor antagonists5-lipoxygenase activating protein inhibitors
TargetsLeukotriene B4 receptor5-lipoxygenase activating protein
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A